Head-to-head · free
908 Devices Inc. vs Mirum Pharmaceuticals, Inc.
MASS vs MIRM — return on capital, cash generation, margins and balance sheet side by side.
MASS
2 / 8
measures where MASS leads
MIRM
6 / 8
measures where MIRM leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | MASS · FY2025 | MIRM · FY2025 |
|---|---|---|
| Revenue | $56.2M | $521.3M |
| Net income | $19.5M | (23.4M) |
| Revenue growth (yearly, multi-year) | 7.4% | 128.5% |
| Free cash flow | (24.6M) | $54.9M |
| Free cash flow margin | -43.9% | 10.5% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | 15.1% | -8.6% |
| Gross margin | 50.6% | 80.8% |
| Operating margin | -45.7% | -4.2% |
| Net debt / EBITDA | — | 6.22x |
Figures are as reported by each company; latest fiscal year shown.
Where 908 Devices Inc.'s cash went (FY2025)
- Capital spending
- $955000
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Mirum Pharmaceuticals, Inc.'s cash went (FY2025)
- Capital spending
- $954000
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free